Skip to main content
# Title Type of news Date Link of news
163 Safety Signal of Nivolumab and the Risk of Capillary Leak Syndrome Signal
162 Safety Signal of Testosterone and the Risk of Atrial Fibrillation Signal
161 Safety Signal of Adalimumab and the Risk of Acute Febrile Neutrophilic Dermatosis Signal
160 Safety Signal of Rivaroxaban and the Risk of Pemphigoid Signal
159 Safety Signal of Encorafenib and the Risk of Tumour lysis syndrome Signal
158 Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Pityriasis Rosea Signal
157 Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Retinal vein occlusion Signal
156 Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Myocardial infarction Signal
155 Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Chronic inflammatory demyelinating polyneuropathy (CIDP) Signal
154 Safety Signal of Progesterone and the Risk of Meningioma Signal
Displaying 31 - 40 of 195